CML - Not only BCR-ABL1 matters
Jenny Rinke, Andreas Hochhaus, Thomas Ernst
Topics & Concepts
Myeloid leukemiaDiseaseEpigeneticsbreakpoint cluster regionCancer researchMedicineStem cellTyrosine kinaseImatinibTyrosine-kinase inhibitorImmunologyOncologyBioinformaticsBiologyInternal medicineGeneticsGeneCancerReceptorChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research